Merkliste 
 1 Ergebnisse 
 
1

Efficacy, patient-reported outcomes, and safety of the anti..:

Buckley, Christopher D ; Simón-Campos, Jesus A ; Zhdan, Vyacheslav...
Efficacy, patient-reported outcomes, and safety of the anti-granulocyte macrophage colony-stimulating factor antibody otilimab (GSK3196165) in patients with rheumatoid arthritis: a randomised, phase 2b, dose-ranging study / C. D Buckley, J. A. Simón-Campos,V. Zhdan [et al.] // The Lancet Rheumatology. – 2020. – Vol. 2, № 11. – P. 677–688. – Режим доступу до журн. : https://doi.org/10.1016/S2665-9913(20)30229-0..  , 2020